DUPIXENT
Live / Registered — Registered — Section 8 accepted (as of 21 Nov 2022)
What this means for you
Registered since 14 Jun 2016. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86807623
- Registration number
- 4978127
- Mark type
- Stylized text
- Filed
- 03 Nov 2015
- Published for opposition
- 29 Mar 2016
- Registered
- 14 Jun 2016
- Attorney of record
- Karen Lim
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of allergies and allergic diseases and disorders, autoimmune diseases and disorders, dermatological diseases and disorders, damaged skin and tissues, gastrointestinal diseases and disorders, inflammation and inflammatory diseases and disorders, respiratory diseases and disorders
Owner
- Sanofi Biotechnology, Paris, FR
- Sanofi Biotechnology, 75008 Paris, FR
- Sanofi Biotechnology, 75008 Paris, FR
Prosecution history
- 14 Jun 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 21 Nov 2022 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 21 Nov 2022 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 21 Nov 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 02 Jun 2022 — TEAS SECTION 8 RECEIVED
- 14 Jun 2021 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 08 Jan 2020 — REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
- 10 Dec 2019 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 05 Apr 2017 — REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
- 31 Jan 2017 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 14 Jun 2016 — REGISTERED-PRINCIPAL REGISTER
- 29 Mar 2016 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 29 Mar 2016 — PUBLISHED FOR OPPOSITION
- 09 Mar 2016 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 25 Feb 2016 — LAW OFFICE PUBLICATION REVIEW COMPLETED